Real‐life effectiveness and safety of guselkumab in patients with psoriasis who have an inadequate response to ustekinumab: A 104‐week multicenter retrospective study – <scp>IL PSO</scp> (<scp>ITALIAN LANDSCAPE PSORIASIS</scp>) - Concepedia

Concepedia

Publication | Open Access

Real‐life effectiveness and safety of guselkumab in patients with psoriasis who have an inadequate response to ustekinumab: A 104‐week multicenter retrospective study – <scp>IL PSO</scp> (<scp>ITALIAN LANDSCAPE PSORIASIS</scp>)

DOI Full Paper Access

32

Citations

19

References

2023

Year

Luigi Gargiulo, Luciano Ibba, Piergiorgio Malagoli, Rosa Giuseppa Angileri, Federico Bardazzi, Nicoletta Bernardini, Martina Burlando, Carlo Giovanni Carrera, Andrea Chiricozzi, Paolo Dapavo,

Journal of the European Academy of Dermatology and Venereology

Abstract

Our data suggest that the efficacy of guselkumab in patients with inadequate response to ustekinumab for plaque psoriasis in 'real-life' clinical practice is comparable with NAVIGATE study with higher percentages of patients achieving PASI90 and PASI100 at weeks 16, 52 and 104.

References

	Year	Citations

Page 1